Vaxcyte, Inc.PCVXNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank19
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P19
Within normal range
vs 5Y Ago
-3.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-56.89%
Q3 2025-18.27%
Q2 202527.13%
Q1 2025-49.26%
Q4 2024-83.50%
Q3 202449.99%
Q2 202423.71%
Q1 2024-23.53%
Q4 2023-123.83%
Q3 20238.28%
Q2 2023-31.56%
Q1 202326.88%
Q4 2022-69.19%
Q3 20221.48%
Q2 2022-41.24%
Q1 202245.78%
Q4 2021-79.81%
Q3 20210.92%
Q2 2021-117.19%
Q1 2021-22.63%
Q4 202017.52%
Q3 2020-42.34%
Q2 202032.72%
Q1 20205.37%
Q4 2019-52.32%
Q3 201930.01%
Q2 2019-38.34%
Q1 20190.00%